▲ BUY
5
/ 10
Conviction
$ Value
$47K
Shares
5,000
Price
$9
Filed
Jun 3
▶ Why this score? (5/10)
- ✓ Open market buy (+3)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
BIENAIME JEAN JACQUES
Title
—
CIK
0001221590
Roles
Director
Transaction Details
Transaction Date
2025-06-03
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
36,415
Footnotes
The weighted average purchase price for the transaction report was $9.38, and the range of prices were between $9.36 and $9.40, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
Filing Info
BIENAIME JEAN JACQUES's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-15 | KROS | ▲ | $12K |
| 2025-06-10 | IMNM | A | $0 |
| 2025-06-10 | INCY | A | $0 |
| 2025-06-10 | INCY | A | $0 |
| 2025-06-04 | KROS | A | $0 |
| 2025-06-04 | KROS | A | $0 |
| 2025-06-03 | IMNM | ▲ | $47K ★ |
Other Insiders at IMNM (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
SIEGALL CLAY B
President and CEO
|
$501K | — | 2026-03-27 |
|
Higgins Jack
Chief Scientific Officer
|
— | $204K | 2026-04-02 |
|
Rosett Max
Chief Financial Officer
|
— | $1.4M | 2026-04-02 |